Roland B. Walter

University of Washington

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (21)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (13)

Charles Craddock

University of Birmingham

UNITED KINGDOM

View details

Ryan D. Cassaday

Washington University School of Medicine

UNITED STATES

View details

Pamela Becker

Professor of Clinical Medicine

University of California, Irvine

UNITED STATES

View details

Jacob Appelbaum

Assistant Professor

University of Washington

UNITED STATES

View details

Stephanie Lee

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

maria ilaria del principe

UNIVERSITY TOR VERGATA

ITALY

View details

Francesco Buccisano

Associate Professor

UNIVERSITY TOR VERGATA

ITALY

View details

Megan Othus

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Mohamed Sorror

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Filippo Milano

Associate Professor

Fred Hutch Cancer Center

UNITED STATES

View details

Phuong Vo

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Sylvie Freeman

University of Birmingham

UNITED KINGDOM

View details

Mary-Elizabeth M. Percival

University of Washington

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Roland B. Walter

Research Interests

Explore related searches

Contact this professor

Articles (21)

Measurable residual disease as predictor of post–day +100 relapses after allografting in adult AML

Relationship between donor source, pre-transplant measurable residual disease, and outcome after allografting for adults with acute myeloid leukemia

CD34+ Cell Dose, Measurable Residual Disease, and Outcome After Myeloablative HLA-Matched Peripheral Blood Hematopoietic Cell Transplantation for Adults with Acute Myeloid Leukemia

Relationship between age, conditioning intensity, and outcome after allografting in adults age ≥60 years with AML

Biobanking and consent to future biospecimen use among adults enrolled in SWOG trials from 2000 to 2024

Modulators of relapse risk in adults allografted for acute myeloid leukemia in measurable residual disease-positive remission

Predictors of Cardiac Recovery in Adults With AML Who Develop Heart Failure During Treatment

Significance of Measurable Residual Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia

Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in Adults over 70 years old

Identification of factors predicting low-risk febrile neutropenia admissions in adults with acute myeloid leukemia

Comparison of reduced intensity and nonmyeloablative conditioning for adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation in first or second remission

Effect of ECOG performance status on outcomes in patients with acute myeloid leukemia and other high-grade myeloid neoplasms

Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AML

Comparison between measurable residual disease relapse and morphologic relapse in acute myeloid leukemia and high-grade myeloid neoplasms

Results from a phase I study of continuous infusion cladribine, high-dose cytarabine, and mitoxantrone for relapsed/refractory high-grade myeloid neoplasms

Poor post-induction outcomes in patients with acute myeloid leukemia previously treated with hypomethylating agents

Association between Prior Cytotoxic Therapy, Antecedent Hematologic Disorder, and Outcome after Allogeneic Hematopoietic Cell Transplantation in Adult Acute Myeloid Leukemia

Significance of measurable residual disease in adults with secondary acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation

Time for Dynamic Assessment of Fitness in Acute Myeloid Leukemia

Association of hematologic response and assay sensitivity on the prognostic impact of measurable residual disease in acute myeloid leukemia: a systematic review and meta-analysis

Relationship Between Pretransplantation Nutritional Status and Outcome in Adults with Acute Myelogenous Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation

Collaborators (13)

Charles Craddock

Ryan D. Cassaday

Pamela Becker

Jacob Appelbaum

Stephanie Lee

maria ilaria del principe

Francesco Buccisano

Megan Othus

Mohamed Sorror

Filippo Milano

Phuong Vo

Sylvie Freeman

Mary-Elizabeth M. Percival

Make your next move.